Drawing for BIOXELL

USPTO serial 78140004

BIOXELL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
THOMAS, AMY E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOXELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey H. Kaufman

JEFFREY H KAUFMAN OBLON SPIVAK MCCLELLAND MAIER & NEUSTADT1940 DUKE STALEXANDRIA, VA 22314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005(Based on Intent to Use) (Based on 44(e)) All purpose disinfectants and pharmaceutical preparations, namely, antiulcerants, antispasmodics, anticholinergics and gastroprokinetics, digestives, including digestive enzymes, anti-diabetics, vitamins, mineral supplements, systemic anabolics, antifibrinolytics, antidotes to anti-coagulants, blood coagulation inhibitors, anti-anaemics, hypolipidaemics, anti-atheromas, fibrinolytics, hematological agents, anti-angiogenesis agents, cardiovascular pharmaceuticals, antihypertensives, anti-ischaemics, dermatological drugs, hair growth agents, erectile dysfunction drugs, antibiotics, sulphonamides and antiviral drugs, anti-parasite agents, genito-urinary system and sex hormones, reproductive system drugs, systemic hormonal preparations, hormones, systemic corticosteroids, thyroid therapeutics, general anti-infective drugs, cytostatics, muscular-skeletal system drugs, uterine mobility drugs, renal function drugs, topical anti-rheumatics, muscle relaxants, anti-gout preparations, anti-inflammatory agents, therapeutic antibodies, immunomodulators, immunostimulators, inimunosuppressants, anti-sepsis and septic shock agents, analgesics, pain control drugs, central nervous system drugs, respiratory system drugs, throat preparations, bronchodilators and anti-asthma preparations, cough and cold treatment preparations, systemic antihistamines, oplitalmological drugs, otological drugs, allergens, diagnostic proteins, diagnostic antibodies, diagnostic nucleic acids, contrast agents, oncological drugs, anti-tumor agents, and anti-proliferative drugsACTIVE—
042(Based on Intent to Use) Research and development services in pharmaceutical and biotechnological fieldACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 20, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 20, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 15, 2010ICNANOTICE OF ALLOWANCE CORRECTION ENTERED—
Apr 15, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 17, 2010FAXXFAX RECEIVED—
Feb 16, 2010NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 24, 2009NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 24, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 16, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 16, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 16, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 14, 2009PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 13, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 13, 2009ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 13, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 12, 2009ALIEASSIGNED TO LIE—
Oct 5, 2009MAILPAPER RECEIVED—
Oct 5, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 5, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 5, 2009ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 7, 2009GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 7, 2009GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 7, 2009CNSISUSPENSION INQUIRY WRITTEN—
Apr 6, 2009RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 5, 2008GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 5, 2008GNSLLETTER OF SUSPENSION E-MAILED—
Oct 5, 2008CNSLSUSPENSION LETTER WRITTEN—
Oct 3, 2008DOCKASSIGNED TO EXAMINER—
Oct 1, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 1, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 29, 2008ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 3, 2008GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 3, 2008GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 3, 2008CNSISUSPENSION INQUIRY WRITTEN—
Apr 3, 2008RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 3, 2008ALIEASSIGNED TO LIE—
Oct 2, 2007GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 2, 2007GNSLLETTER OF SUSPENSION E-MAILED—
Oct 2, 2007CNSLSUSPENSION LETTER WRITTEN—
Oct 1, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 1, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 1, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 2, 2007GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 2, 2007CNSISUSPENSION INQUIRY WRITTEN—
Oct 2, 2006GNSLLETTER OF SUSPENSION E-MAILED—
Oct 2, 2006CNSLSUSPENSION LETTER WRITTEN—
Oct 2, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Sep 21, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 21, 2006MAILPAPER RECEIVED—
Apr 20, 2006GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 20, 2006CNSISUSPENSION INQUIRY WRITTEN—
Oct 20, 2005GRMLCORRESPONDENCE E-MAILED—
Oct 20, 2005CNSLSUSPENSION LETTER WRITTEN—
Oct 19, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 11, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 11, 2005MAILPAPER RECEIVED—
Apr 8, 2005GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 8, 2005CNSISUSPENSION INQUIRY WRITTEN—
Oct 8, 2004GNSLLETTER OF SUSPENSION E-MAILED—
Oct 8, 2004CNSLSUSPENSION LETTER WRITTEN—
Oct 7, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Sep 27, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 27, 2004MAILPAPER RECEIVED—
Mar 27, 2004GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 22, 2003GNSLLETTER OF SUSPENSION E-MAILED—
Aug 19, 2003CFITCASE FILE IN TICRS—
Jul 29, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 29, 2003MAILPAPER RECEIVED—
Jun 24, 2003GNSLLETTER OF SUSPENSION E-MAILED—
Jun 3, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2003MAILPAPER RECEIVED—
Dec 3, 2002GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 29, 2002MAILPAPER RECEIVED—
Nov 27, 2002DOCKASSIGNED TO EXAMINER—
Sep 23, 2002AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Sep 23, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 23, 2002MAILPAPER RECEIVED—

Frequently asked questions

Related guidance